Label-Free Enrichment of Circulating Tumor Cells (CTCs).

Heterogeneity Resolved with Specificity 

Facilitating rapid discovery and development of potentially predictive signatures with the most advanced view of immuno-oncology biology.

The pursuit of a cure has taken a decisive new turn. nCounter SPRINT represents the most affordable product variation of a powerful new technology that is changing the face of cancer research. You can now exploit the benefits of nCounter technology in your research.

Enabling High-Plex Expression Analysis and Reduces Hands-on Time as Compared to qPCR.

Don’t let sample volume limit your analytical aspirations. Detect DNA, RNA, and protein changes in a single assay to use less precious material and gather more informative data.

Quantify protein and gene expression in one experiment with nCounter® Vantage 3D™ Immune Assays. Our immune assays are designed to complement our 770-plex immune-focused mRNA panel for in-depth characterization of up to 800 total targets:

Complementary companion advanced analysis software for Nanostring nCounter.

Guest Scientist: Dr Caroline Chan,Senior Field Application Scientist, Nanostring (USA)

3rd October 2017 (Tuesday)  |  10:30 - 11:30 AM  |  Conference Room 1, INFORMM, USM Penang

Guest Scientist: Dr Doug Hinerfeld, Principal Product Application Scientist, Nanostring (USA)

30th October 2017 (Monday)  |  9:00 - 11:00 AM  |  Seminar Room 2, Level 1, High Impact Research (HIR), University Malaya

Guest Scientist: Dr Caroline Chan,Senior Field Application Scientist, Nanostring (USA)

17th August 2017 (Thursday)  |  2:30 - 3:30 PM  |  Main Meeting Room, FPSK,Universiti Sains Islam Malaysia (USIM)